Med Chem Res
1670, 1628, 1623, 1600, 1557, 1515, 1500, 1306, 1225,
1074, 1025, 913, 849, 745, 698; 1H NMR (400 MHz,
CDCl3): d 10.97 (s, 1H), 8.42 (s, 1H), 7.20 (dd, J = 3.6,
1.9 Hz, 5H), 7.15–6.90 (m, 4H), 6.86–6.77 (m, 1H), 6.47
(d, J = 15.2 Hz, 1H), 6.06 (s, 2H), 4.94 (d, J = 15.2 Hz,
1H), 4.73 (t, J = 6.0 Hz, 1H), 3.30 (dd, J = 12.4, 6.1 Hz,
1H), 3.05 (dd, J = 12.4, 6.0 Hz, 1H); 13C NMR (100 MHz,
CDCl3): d 106.3, 131, 122.5, 108.5, 148.2, 147.7, 101.3,
138.2, 126.4, 142.8, 122.8, 165.1, 135.1, 127.0, 128.8, 129.4,
55.5, 175.0, 37.8; m/z 365.13.
148.2, 147.7, 164.9, 142.3, 138.2, 136.6, 132.4, 126.4,
122.7, 122.3, 119.4, 101.3; m/z 371.02.
Results and discussion
Combining different active molecules present in nature,
results in enhancement of their bioavailability. These mol-
ecules contain the unique properties like chirality, hydro-
philicity/hydrophobicity, and optical properties (Frank-Frut
and Krishnan, 2003; Thiantanwat et al., 2000). Piperine (1),
obtained from the extraction of dried seeds of Piper nigrum,
was converted into acid by hydrolysis using ethanolic KOH
and Con. HCl. The acid is converted into acid chloride using
thionyl chloride which provides an electron-deficient acid
carbonyl center followed by condensation with amine in
dichloromethane. The piperidine amide of natural piperine
was replaced by different aminoacids and substituted aniline
to obtain compounds 4a–4e. All the tested compounds
(4a–4e) were characterized by 1H, 13C NMR, IR, and LCMS
analysis. The IR peaks at 1,630–1,690 cm-1 for all the
synthesized compounds arise due to the t C=O and those at
3,500–3,700 cm-1 are due to the t N–H.
The cytotoxic activity was carried out by MTT assay
and the results were summarized in Table 1. The synthe-
sized compounds (4a–4e) were screened for their cytotoxic
activity against Hela and Breast cancer cell lines. The IC50
value for piperine is 0.95 and 0.99 lmol against hela and
breast cancer cell lines, respectively. Compound 4c, a
tryptophan analog of piperine which possesses heterocyclic
aromatic ring, showed highest growth inhibition against
hela cell lines (IC50—0.736 lmol) and breast cancer cell
lines (IC50—0.87 lmol). Compound 4a, a histidine analog
of piperine containing imidazole ring structure, showed
highest cytotoxic activity against breast cancer cell line
(IC50—0.74 lmol). From the data, we summarize that the
activity of all the synthesized compounds was found to be
better than that of piperine. The antibacterial assay was
carried out by serial dilution method, and the MIC values
were recorded and summarized in Table 2. Among all the
tested compounds, compound 4e containing p-bromoaniline
nucleus was found to be the best against K. pneumoniae.
Compound 4b containing phenyl alanine skeleton was active
against S. dysenteriae compared with all other tested com-
pounds. The MIC values of most of all the tested compounds
were as good as or even better than piperine.
2-[[(2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-
dienoyl]amino]-3-(1H-indol-3-yl)propanoic acid (4c)
It is a colorless solid, molecular formula: C23H20N2O5;
m. p. 135–137 °C; IR (KBr) tmax: 1660, 1675, 700, 500,
1300–700 (indole ring), 1230, 1160, 1115, 1045, 770,
1
1375, 3410, 3650, 1680, 1628, 1600, 1515, and 1500; H
NMR (400 MHz, CDCl3): d 11.02 (s, 1H), 8.42 (s, 1H),
7.72 (s, 1H), 7.58 (dd, J = 7.5, 1.7 Hz, 1H), 7.36–7.29 (m,
1H), 7.20 (s, 1H), 7.15–6.86 (m, 6H), 6.72 (dt, J = 15.1,
1.1 Hz, 1H), 6.53 (d, J = 15.2 Hz, 1H), 6.06 (s, 2H), 5.31
(d, J = 15.2 Hz, 1H), 4.85 (t, J = 5.1 Hz, 1H), 3.38 (dd,
J = 12.4, 5.0 Hz, 1H), 3.12 (dd, J = 12.3, 5.1 Hz, 1H);
13C NMR (100 MHz, CDCl3): d 106.3, 112.0, 121.3, 119.6,
118.1, 124.7, 136.3, 127.9, 110.9, 28.2, 174.6, 52.5, 165.1,
122.8, 142.8, 126.4, 138.2, 101.3, 147.7, 148.2, 108.5,
122.5, 131.6; m/z 404.14.
(2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(4-
chlorophenyl)penta-2,4-dienamide (4d)
It is a colorless solid, molecular formula: C18H14ClNO3;
m. p. 139–141 °C; IR (KBr) tmax: 3600, 1618, 1495, 1281,
1174, 1082, 1005, 821, 630, 500, 1670, 1628, 1685, 1600,
1
1515, 1500; H NMR (400 MHz, CDCl3): d 9.52 (s, 1H),
7.89–7.81 (m, 2H), 7.44–7.36 (m, 2H), 7.15–7.02 (m, 3H),
6.97–6.82 (m, 2H), 6.68 (d, J = 15.0 Hz, 1H), 6.06 (s, 2H),
5.27 (d, J = 15.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): d
106.3, 131.0, 122.52, 108.5, 148.2, 147.7, 101.3, 138.2, 126.4,
142.3, 122.3, 164.9, 137.0, 128.4, 127.8, 122.0; m/z 327.07.
(2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(4-
bromophenyl)penta-2,4-dienamide (4e)
It is a pale white color solid, molecular formula:
C18H14BrNO3; m.p. 145–148 °C; IR (KBr) tmax: 3565,
1618, 1495, 1291, 1164, 1082, 1005, 821, 630, 500, 1650,
1628, 1670, 1600, 1515, 1500; 1H NMR (400 MHz,
CDCl3): d 9.52 (s, 1H), 7.54–7.46 (m, 2H), 7.42–7.34 (m,
2H), 7.15–7.02 (m, 2H), 6.94 (d, J = 7.5 Hz, 1H),
6.85–6.70 (m, 3H), 6.06 (s, 2H), 5.40 (d, J = 14.9 Hz, 1H);
13C NMR (100 MHz, CDCl3): d 106.3, 131.0, 122.5, 108.5,
Conclusion
We conclude that the synthetic analogs of piperine were
superior to piperine with respect to both cytotoxic and
antibacterial efficacy.
123